De; Biswanath
Patent Applications and Registrations
Patent applications and USPTO patent grants for De; Biswanath.The latest application filed is for "quindoline compounds and uses thereof".
Company Profile
1.43.34
- De; Biswanath - Tucson AZ
- De; Biswanath - Oro Valley AZ
- De; Biswanath - Cincinnati OH
- De, Biswanath - US
- De; Biswanath - Cincinatti OH
- De; Biswanath - Mason OH
- De; Biswanath - Buffalo Grove IL
- De; Biswanath - Vernon Hills IL
Patent Activity
| Patent | Date |
|---|---|
| Quindoline Compounds And Uses Thereof App 20220098210 - Hurley; Laurence ; et al. | 2022-03-31 |
| C16 unsaturated FP-selective prostaglandins analogs Grant RE43,372 - deLong , et al. May 8, 2 | 2012-05-08 |
| Tri-substituted ureas as cytokine inhibitors Grant 7,449,474 - Brugel , et al. November 11, 2 | 2008-11-11 |
| Tri-substituted ureas as cytokine inhibitors Grant 7,402,589 - Brugel , et al. July 22, 2 | 2008-07-22 |
| Pyrrolo[2,3-d]pyrimidine cytokine inhibitors App 20080139588 - Clark; Michael Philip ; et al. | 2008-06-12 |
| Pyrrolo[2,3-d]pyrimidine cytokine inhibitors Grant 7,319,102 - Clark , et al. January 15, 2 | 2008-01-15 |
| Purine cytokine inhibitors Grant 7,256,196 - Sabat , et al. August 14, 2 | 2007-08-14 |
| Interleukin-1.beta. converting enzyme inhibitors Grant 7,138,395 - O'Neil , et al. November 21, 2 | 2006-11-21 |
| 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia Grant 7,087,615 - Clark , et al. August 8, 2 | 2006-08-08 |
| Interleukin-1.beta. converting enzyme inhibitors Grant 7,041,696 - Wos , et al. May 9, 2 | 2006-05-09 |
| Interleukin converting enzyme inhibitors Grant 7,001,899 - Wos , et al. February 21, 2 | 2006-02-21 |
| Tri-substituted ureas as cytokine inhibitors App 20050245555 - Brugel, Todd Andrew ; et al. | 2005-11-03 |
| Tri-substituted ureas as cytokine inhibitors App 20050239811 - Brugel, Todd Andrew ; et al. | 2005-10-27 |
| Heterocyclic side chain containing, n-substituted metalloprotease inhibitors Grant 6,949,545 - Pikul , et al. September 27, 2 | 2005-09-27 |
| Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,919,346 - Clark , et al. July 19, 2 | 2005-07-19 |
| Substituted cyclic amine metalloprotease inhibitors App 20050154019 - Natchus, Michael George ; et al. | 2005-07-14 |
| Substituted cyclic amine metalloprotease inhibitors App 20050137248 - Natchus, Michael George ; et al. | 2005-06-23 |
| Substituted cyclic amine metalloprotease inhibitors App 20050101567 - Natchus, Michael George ; et al. | 2005-05-12 |
| Substituted cyclic amine metalloprotease inhibitors Grant 6,872,742 - Natchus , et al. March 29, 2 | 2005-03-29 |
| Substituted cyclic amine metalloprotease inhibitors Grant 6,858,628 - Natchus , et al. February 22, 2 | 2005-02-22 |
| Difluorobutyric acid metalloprotease inhibitors Grant 6,852,751 - Pikul , et al. February 8, 2 | 2005-02-08 |
| Fused pyrazolone compounds which inhibit the release of inflammatory cytokines Grant 6,821,971 - Clark , et al. November 23, 2 | 2004-11-23 |
| Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,790,846 - Clark , et al. September 14, 2 | 2004-09-14 |
| Triazole compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,787,555 - Tullis , et al. September 7, 2 | 2004-09-07 |
| Beta disubstituted metalloprotease inhibitors App 20040142975 - Pikul, Stanislaw ; et al. | 2004-07-22 |
| Substituted cyclic amine metalloprotease inhibitors App 20040138260 - Natchus, Michael George ; et al. | 2004-07-15 |
| Dihetero-substituted metalloprotease inhibitors Grant 6,762,198 - Cheng , et al. July 13, 2 | 2004-07-13 |
| Heterocyclic side chain containing, n-substituted metalloprotease inhibitors App 20040127498 - Pikul, Stanislaw ; et al. | 2004-07-01 |
| Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity App 20040122025 - Clark, Michael Philip ; et al. | 2004-06-24 |
| 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia App 20040087639 - Clark, Michael Philip ; et al. | 2004-05-06 |
| 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines Grant 6,730,668 - Clark , et al. May 4, 2 | 2004-05-04 |
| Triazole compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,727,364 - Tullis , et al. April 27, 2 | 2004-04-27 |
| Beta disubstituted metalloprotease inhibitors Grant 6,696,456 - Pikul , et al. February 24, 2 | 2004-02-24 |
| Novel interleukin-1beta converting enzyme inhibitors App 20040014753 - O'Neil, Steven Victor ; et al. | 2004-01-22 |
| Interleukin converting enzyme inhibitors App 20040009966 - Wos, John August ; et al. | 2004-01-15 |
| 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines Grant 6,677,337 - Laufersweiler , et al. January 13, 2 | 2004-01-13 |
| Novel interleukin-1beta converting enzyme inhibitors App 20030236296 - Wos, John August ; et al. | 2003-12-25 |
| 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines App 20030225082 - Laufersweiler, Matthew John ; et al. | 2003-12-04 |
| Dihetero-substituted metalloprotease inhibitors App 20030225074 - Cheng, Menyan ; et al. | 2003-12-04 |
| Substituted cyclic amine metalloprotease inhibitors App 20030191163 - Natchus, Michael George ; et al. | 2003-10-09 |
| Heterocyclic metalloprotease inhibitors App 20030186958 - De, Biswanath ; et al. | 2003-10-02 |
| Heterocyclic side chain containing metalloprotease inhibitors App 20030171400 - Pikul, Stanislaw ; et al. | 2003-09-11 |
| Carbocyclic side chain containing metalloprotease inhibitors App 20030162778 - Natchus, Michael George ; et al. | 2003-08-28 |
| Carbocyclic side chain containing, N-substituted metalloprotease inhibitors App 20030144292 - Natchus, Michael George ; et al. | 2003-07-31 |
| Heterocyclic side chain containing, n-substituted metalloprotease inhibitors App 20030139414 - Pikul, Stanislaw ; et al. | 2003-07-24 |
| Difluorobutyric acid metalloprotease inhibitors App 20030139453 - Pikul, Stanislaw ; et al. | 2003-07-24 |
| 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines App 20030134867 - Clark, Michael Philip ; et al. | 2003-07-17 |
| 1,3-Diheterocyclic metalloprotease inhibitors App 20030130271 - Pikul, Stanislaw ; et al. | 2003-07-10 |
| C16 unsaturated FP-selective prostaglandins analogs Grant 6,586,463 - deLong , et al. July 1, 2 | 2003-07-01 |
| Compound which inhibit the release of inflammatory cytokines App 20030105084 - Clark, Michael Philip ; et al. | 2003-06-05 |
| Substituted cyclic amine metalloprotease inhibitors App 20030105153 - Natchus, Michael George ; et al. | 2003-06-05 |
| Triazole compounds useful in treating diseases associated with unwanted cytokine activity App 20030100558 - Tullis, Joshua Spector ; et al. | 2003-05-29 |
| Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity App 20030096814 - Clark, Michael Philip ; et al. | 2003-05-22 |
| Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines Grant 6,566,357 - Laufersweiler , et al. May 20, 2 | 2003-05-20 |
| Heterocyclic metalloprotease inhibitors Grant 6,545,038 - De , et al. April 8, 2 | 2003-04-08 |
| Triazole compounds useful in treating diseases associated with unwanted cytokine activity App 20030013712 - Tullis, Joshua Spector ; et al. | 2003-01-16 |
| C16 unsaturated FP-selective prostaglandins analogs Grant 6,451,859 - deLong , et al. September 17, 2 | 2002-09-17 |
| Substituted cyclic amine metalloprotease inhibitors App 20020072517 - Natchus, Michael George ; et al. | 2002-06-13 |
| Substituted cyclic amine metalloprotease inhibitors App 20020061877 - Natchus, Michael George ; et al. | 2002-05-23 |
| 2-decarboxy-2-phosphinico Prostaglandin F analogs Grant 6,372,730 - deLong , et al. April 16, 2 | 2002-04-16 |
| C16 unsaturated FP-selective prostaglandins analogs App 20020037913 - deLong, Mitchell Anthony ; et al. | 2002-03-28 |
| Substituted pyrrolidine hydroxamate metalloprotease inhibitors Grant 6,329,418 - Cheng , et al. December 11, 2 | 2001-12-11 |
| Acyclic metalloprotease inhibitors Grant 6,218,389 - Almstead , et al. April 17, 2 | 2001-04-17 |
| Bidentate metalloprotease inhibitors Grant 6,121,272 - Almstead , et al. September 19, 2 | 2000-09-19 |
| Aromatic C.sub.16 -C.sub.20 -substituted tetrahydro prostaglandins useful as FP agonists Grant 6,107,338 - Wos , et al. August 22, 2 | 2000-08-22 |
| Aromatic C16-C20 substituted tetrahydro prostaglandins useful as FP agonists Grant 6,048,895 - Wos , et al. April 11, 2 | 2000-04-11 |
| Aromatic C.sub.16 -C.sub.20 -substituted tetrahydro prostaglandins useful as FP agonists Grant 5,977,173 - Wos , et al. November 2, 1 | 1999-11-02 |
| Phosphinic acid amides as matrix metalloprotease inhibitors Grant 5,830,915 - Pikul , et al. November 3, 1 | 1998-11-03 |
| Lactam-containing hydroxamic acids Grant 5,672,598 - De , et al. September 30, 1 | 1997-09-30 |
| Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists Grant 5,364,869 - De November 15, 1 | 1994-11-15 |
| Angiotensin II receptor antagonists Grant 5,326,776 - Winn , et al. July 5, 1 | 1994-07-05 |
| Angiotensin II receptor antagonists Grant 5,250,548 - Winn , et al. October 5, 1 | 1993-10-05 |
| 1,3-oxazolyl substituted biphenyl Grant 5,210,206 - Morton , et al. May 11, 1 | 1993-05-11 |
| Heterocyclic peptide renin inhibitors Grant 5,164,388 - De , et al. November 17, 1 | 1992-11-17 |
| Candida acid protease inhibiting compounds Grant 5,120,718 - Goldman , et al. June 9, 1 | 1992-06-09 |
| Heterocyclic renin inhibitors Grant 4,994,477 - Kempf , et al. February 19, 1 | 1991-02-19 |
| Dopamine agonists Grant 4,963,568 - Schoenleber , et al. October 16, 1 | 1990-10-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 